Pattern of care and outcome in elderly patients with glioblastoma: Data in 151 patients from 3 Lombardia Hospitals

被引:11
作者
Rigamonti, Andrea [1 ]
Imbesi, Francesca [2 ]
Silvani, Antonio [3 ]
Grimod, Gianluca [4 ]
Prone, Valentina [2 ]
Gaviani, Paola [3 ]
Ardizzoia, Antonio [5 ]
Milanesi, Ida [6 ]
Arienti, Virginia [7 ]
Agostoni, Elio [2 ]
Di Meco, Francesco [8 ]
Salmaggi, Andrea [1 ]
机构
[1] ASST Lecco, Dept Neurol, Via DellEremo 9-11, I-23900 Lecce, Italy
[2] ASST Grande Osped Metropolitan Niguarda, Dept Neurol, Piazza Osped Maggiore 3, I-20162 Milan, Italy
[3] Fdn IRCSS Carlo Besta, Neuro Oncol Unit, Via Celoria 11, I-20133 Milan, Italy
[4] ASST Lecco, Neurosurg, Via DellEremo 9-11, I-23900 Lecce, Italy
[5] ASST Lecco, Oncol, Via DellEremo 9-11, I-23900 Lecce, Italy
[6] Fdn IRCSS Carlo Besta, Radiotherapy, Via Celoria 11, I-20133 Milan, Italy
[7] ASST Grande Osped Metropolitan Riguarda, Radiotherapy, Piazza Osped Maggiore 3, I-20162 Milan, Italy
[8] Fdn IRCSS Carlo Besta, Unit Neurosurg 1, Via Celoria 11, I-20133 Milan, Italy
关键词
Glioblastoma; Elderly; Survival; Radiotherapy; Chemotherapy; Extent of resection; ADJUVANT TEMOZOLOMIDE; HYPOFRACTIONATED RADIOTHERAPY; CONCOMITANT TEMOZOLOMIDE; PLUS CONCOMITANT; OLDER PATIENTS; VALPROIC ACID; SURVIVAL; MULTIFORME; LEVETIRACETAM; CHEMOTHERAPY;
D O I
10.1016/j.jns.2017.04.030
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The appropriate treatment approach for elderly patients with glioblastoma multiforme (GBM) is unclear, although different studies suggest survival benefit in fit patients treated with radiotherapy and chemiotherapy after surgery. We performed a retrospective analysis of 151 patients older than 65 years with GBM treated in 3 Lombardia Hospitals. In univariate regression analysis higher KPS (p = 0.02), macroscopical total resection (p < 0.003), radiotherapy (p < 0.0001), chemotherapy (p < 0.0001) and second line chemotheraphy (p = 0.02) were of positive prognostic value. On the contrary older age (>70 years), presence of seizure at onset and additional resection after tumor recurrence did not influence OS. Multivariate analysis revealed radiotherapy (HR 0.2 p < 0.0001) and extent of surgery (HR 0.3, p = 0,0063) as positive independent prognostic factors. Patients receiving radio-chemiotherapy displayed more treatment-related toxicities with a slightly prolonged OS versus those receiving hypofractionated radiotherapy. With the limits of a retrospective study, our data suggest that in elderly fit patients extensive surgery should be considered, moreover adjuvant treatments led to an increase in OS. Randomized controlled study are needed to develop treatment guidelines for elderly GBM patients and to assess whether the combination of post-surgical radio and chemiotherapy may be superior to hypofractionated radiotherapy and chemiotherapy in fit patients. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:3 / 8
页数:6
相关论文
共 41 条
  • [1] [Anonymous], INT J RAD ONCOL BIOL
  • [2] [Anonymous], NEUROL MED CHIN TOKY
  • [3] Radiotherapy and concomitant temozolomide may improve survival of elderly patients with glioblastoma
    Barker, Christopher A.
    Chang, Maria
    Chou, Joanne F.
    Zhang, Zhigang
    Beal, Kathryn
    Gutin, Philip H.
    Iwamoto, Fabio M.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2012, 109 (02) : 391 - 397
  • [4] Patterns of care and outcomes among elderly individuals with primary malignant astrocytoma
    Barnholtz-Sloan, Jill S.
    Williams, Vonetta L.
    Maldonado, John L.
    Shahani, Dilip
    Stockwell, Heather G.
    Chamberlain, Marc
    Sloan, Andrew E.
    [J]. JOURNAL OF NEUROSURGERY, 2008, 108 (04) : 642 - 648
  • [5] Concomitant and adjuvant temozolomide of newly diagnosed glioblastoma in elderly patients
    Behm, Timo
    Horowski, Antonia
    Schneider, Simon
    Bock, Hans Christoph
    Mielke, Dorothee
    Rohde, Veit
    Stockhammer, Florian
    [J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2013, 115 (10) : 2142 - 2146
  • [6] Levetiracetam enhances p53-mediated MGMT inhibition and sensitizes glioblastoma cells to temozolomide
    Bobustuc, George C.
    Baker, Cheryl H.
    Limaye, Arati
    Jenkins, Wayne D.
    Pearl, Gary
    Avgeropoulos, Nicholas G.
    Konduri, Santhi D.
    [J]. NEURO-ONCOLOGY, 2010, 12 (09) : 917 - 927
  • [7] Treatment decisions in elderly patients with glioblastoma
    Brandes, Alba A.
    Bartolotti, Marco
    [J]. NATURE REVIEWS NEUROLOGY, 2012, 8 (12) : 664 - 665
  • [8] Temozolomide Concomitant and Adjuvant to Radiotherapy in Elderly Patients With Glioblastoma Correlation With MGMT Promoter Methylation Status
    Brandes, Alba A.
    Franceschi, Enrico
    Tosoni, Alicia
    Benevento, Francesca
    Scopece, Luciano
    Mazzocchi, Valeria
    Bacci, Antonella
    Agati, Raffaele
    Calbucci, Fabio
    Ermani, Mario
    [J]. CANCER, 2009, 115 (15) : 3512 - 3518
  • [9] Hypofractionated radiotherapy with or without concurrent temozolomide in elderly patients with glioblastoma multiforme: a review of ten-year single institutional experience
    Cao, Jeffrey Q.
    Fisher, Barbara J.
    Bauman, Glenn S.
    Megyesi, Joseph F.
    Watling, Christopher J.
    Macdonald, David R.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2012, 107 (02) : 395 - 405
  • [10] Surgical outcomes for older patients with glioblastoma multiforme: preoperative factors associated with decreased survival Clinical article
    Chaichana, Kaisorn L.
    Chaichana, Khan K.
    Olivi, Alessandro
    Weingart, Jon D.
    Bennett, Richard
    Brem, Henry
    Quinones-Hinojosa, Alfredo
    [J]. JOURNAL OF NEUROSURGERY, 2011, 114 (03) : 587 - 594